Navigation Links
Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too
Date:8/29/2007

e the norovirus outbreak was citywide, staff from outside of JHH were not allowed to work on site, while Hopkins staff, in turn, were banned from working at other facilities. Even visitors to the Hospital were asked screening questions to identify stomach problems and, if present, were told not to see patients for 72 hours. Staff working on units hit by the outbreak wore gowns and gloves to guard against unwittingly picking up or spreading the disease. All group meals or shared-food events were banned inside the Hospital.

After three months of intense efforts to prevent the spread of infection, new infections stopped by early May 2004. The outbreak was deemed to be over, and affected units returned to normal activity.

The researchers review showed that the number of patients infected, or so-called attack rate of the virus, in the CCU was low, at 5 percent (seven patients out of 133), but was notably higher for health care workers, at 30 percent (29 out of 97). The attack rate numbers were higher for psychiatry services, at 17 percent for patients (39 out of 233) and 38 percent for staff (76 out of 200).

Everyone infected experienced diarrhea or vomiting, while some others experienced such symptoms as chills and muscle aches.

Calculations of costs associated with the cleanup included expenses for cleaning supplies ($96,000), staff sick leave and overtime ($89,000), plus lost revenue from closing the units and echocardiogram laboratory to new patients ($418,000). Indeed, nearly 460 hours of sick leave were used by staff on the CCU, 138 hours in the echocardiogram lab, and more than 2,000 hours in psychiatry services.

Expenses not taken into account were those associated with other areas of the hospital where few cases were reported and no restrictions were placed on the unit. Costs incurred outside of main units were not included in this estimate because researchers were not certain that the infection had indeed
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Norwalk Bug Takes 260 Students and Some Teachers for a Ride!
2. Norwalk Virus Outbreak in a Toronto Hospital
3. Norwalk Virus Forces Closure Of Canadian Hospital
4. For West Nile Virus: Prevention Is The Watchword
5. Five in Turkey infected with H5N1 virus: health official
6. No Mutation Of Bird Flu Virus: WHO
7. Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
8. Rhinovirus: You Cannot Give a Cold Shoulder to Hotel Freebies!
9. 115 people on board a cruise liner taken ill due to suspected Norovirus
10. CDC reveals relationship between prepregnant weight and heart defects in infants
11. Ovarian cancer in relationship with Hormone therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, HARRISBURG,Pa.,Nov.24/PRNewswire-USNewswire/...Pennsylvaniansat-riskfortheH1N1fluwerevaccinateddu...mentofHealthandlocalhealthdepartments. ,, "With...esandprojectionsregardingtheavailabilityofH1N1vacc...ndell."Overall,wearepleasedwiththeH1N1vaccinedistr...
(Date:11/24/2009)...,, SANBERNARDINO,Calif.,Nov.24/PRNewswire/--Nex...cationseminarsaimedathelpingHispanic-Americansenio...r,seniorsareencouragedtotakeafreeZumba®Goldcl...msofmerengue,salsa,cumbia,rumba,andtango. ,, Un...ticipantsfeelcomfortableandengagedwhenlearningabou...
(Date:11/24/2009)...,, BIRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/...itwillparticipateintheBankofAmericaMerrillLynch200...althSouthSeniorVicePresidentandTreasurerEdFaywillb...sentationwillbewebcastliveandwillbeavailableat htt...lelink. ,, AboutHealthSouth ,, HealthSouth...
(Date:11/24/2009)...udy finds that quitting improves heart prospects, .... 24 (HealthDay News) -- A new study offers yet mo...eath from heart disease and cancer. , Researche...female smokers, formers smokers and nonsmokers for...re 4.16 times more likely to die of cancer, 2.26 t...
(Date:11/24/2009)...November 18, 2009 - Oakland, Calif. A study condu...and scientists identifies a new class of therapeut...and possibly treat colon cancer, the third most de...al lipid molecules found in soy that research show... study, led by Julie Saba, MD, PhD, senior scienti...
Breaking Medicine News(10 mins):Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2
...RIVERSIDE, Calif. UC Riversides Douglas Ethell ,... studies how brain cells die in disorders such as ...20,833, five-year grant by the California Institut...esearch on human embryonic stem cells for treating...
...ION VIEJO, Calif., Dec. 13 The Ensign,Group, Inc....n(TM) group of,skilled nursing, rehabilitative car...d today that it completed the purchase of two skil...go: http://www.newscom.com/cgi-bin/prnh/20071213/...
...AGO, Dec. 13 Advanced Life Sciences,Holdings, Inc...gaged in the,discovery, development and commercial... infection, cancer and inflammation, today announc...illion shares of common stock to a group of new an...
...SBAD, Calif., Dec. 13 Isis,Pharmaceuticals, Inc. ...d and,Drug Administration (FDA) has granted orphan...n inherited form of amyotrophic lateral sclerosis ...ad to death. ISIS 333611, a second-generation anti...
...-term treatment after drug-eluting stents is key, ...remely important after implanting a drug-eluting s...to updated joint Guidelines for Percutaneous,Coron... guidelines also note that the artery-opening proc...
...CA, N.Y., Dec. 13 Capsulated Systems, Inc. at its...veloped a new proprietary,micro-particle system th...asting at least five days in vivo according to its...r a long acting,local anesthetic without the commo...
Other Medicine News:Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 3Health News:The Ensign Group, Inc. Acquires Assets of Three Previously Leased Facilities 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 2Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 3Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 4Health News:American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement 5Health News:Capsulated Systems, Inc. Develops Long Term Local Anesthetic 2
(Date:11/24/2009)...d.,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings,In...ipatinginthe21stAnnualPiperJaffrayHealthCareConfer...asternTime. ,, Alivewebcastofthepresentationcan...tp://investor.zimmer.com .Thewebcastwillbearchived...mpany ,, Foundedin1927andheadquarteredinWarsaw...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Orexigen®Therap...nyfocusedonthetreatmentofobesity,todayannouncedtha...pany,sBoardofDirectorsgrantedaninducementstockopti...ssen,M.D.,itsnewlyappointedHeadoftheGlobalContrave...tivestockoptiontotheextentpermittedbylawandhasanex...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc...ndevelopingandcommercializingnovelpainmanagementth...oitsBoardofDirectors,effectiveNovember19,2009.Mr.O...maceuticalindustryandhasbeeninstrumentalinthelaunc...rentlyservesasSeniorVicePresident,BioOncologyBusin...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Cardiac Science Announces Third Quarter Results 6112 1Cardiac Science Announces Third Quarter Results 6112 2Cardiac Science Announces Third Quarter Results 6112 3Cardiac Science Announces Third Quarter Results 6112 4Cardiac Science Announces Third Quarter Results 6112 5Cardiac Science Announces Third Quarter Results 6112 6Cardiac Science Announces Third Quarter Results 6112 7Cardiac Science Announces Third Quarter Results 6112 8Cardiac Science Announces Third Quarter Results 6112 9Cardiac Science Announces Third Quarter Results 6112 10Cardiac Science Announces Third Quarter Results 6112 11Cardiac Science Announces Third Quarter Results 6112 12Cardiac Science Announces Third Quarter Results 6112 13Cardiac Science Announces Third Quarter Results 6112 14Cardiac Science Announces Third Quarter Results 6112 15Cardiac Science Announces Third Quarter Results 6112 16Cardiac Science Announces Third Quarter Results 6112 17Cardiac Science Announces Third Quarter Results 6112 18Cardiac Science Announces Third Quarter Results 6112 19Cardiac Science Announces Third Quarter Results 6112 20Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 2Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 3Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 4Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 5Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 1Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 2Pharmasset to Present at Lazard Capital Markets Healthcare Conference 6106 3
...stant Skin Infections, SAN DIEGO, Sept. 22 Trius... of Phase 2 testing of the oral form of its,second...1. The multicenter,trial will test the efficacy, s... 300 and 400 milligrams of TR-701 in complicated s... to seven days of treatment., The study follows t...
... the Injectable Filler Market, PALO ALTO, Calif.,...launch of its Novielle Voice family of injectable ...n Academy of Otolaryngology -- Head,and Neck Surge...., The U.S. Food and Drug Administration (FDA) cl...s earlier this year for restoration of voice loss....
Other Medicine Technology:Trius Doses First Patient in Antibacterial Phase 2 Trial 2Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss 2
Laboratory Workstation; Vibration-Free Platform
TXG Series Stool 1G65
Adjustable Chrome-Plated Stool
...he ideal modular cleanroom for biological safety l...uire cleanliness (to Class 10/ISO 3) and easy ster...ltra-smooth surfaces that are easy to wipe down an...ning. Unique double-wall panel design creates stro...
Medicine Products: